MARYLAND CAPITAL ADVISORS INC.

Position in OGN — Organon & Co.

CIK 1891201 CHESTER, MD

Position in OGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$3,425

+$1,633 QoQ

Shares Held

253

+1.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#384

of 626 holders

Holding Since

Dec 2021

18 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MARYLAND CAPITAL ADVISORS INC. holds $1,214,787 across 12 Drug Manufacturers - General names. OGN ranks #7 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,448	$367,747
2	MRK	Merck & Co., Inc.	2,577	$331,144
3	AMGN	Amgen Inc	698	$252,759
4	ABBV	AbbVie Inc.	963	$242,329
5	AZN	Astrazeneca PLC	38	$7,205
6	NVS	Novartis AG	39	$6,112
7	OGN	Organon & Co. This page	253	$3,425
8	LLY	ELI LILLY & Co	2	$2,398

18 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,425	253	+1.2%	Shares	Sole	2026-07-17
2025-12-31	$1,792	250	0.0%	Shares	Sole	2026-01-20
2025-09-30	$2,670	250	0.0%	Shares	Sole	2025-10-17
2025-06-30	$2,420	250	0.0%	Shares	Sole	2025-07-14
2025-03-31	$3,722	250	0.0%	Shares	Sole	2025-05-06
2024-12-31	$3,730	250	0.0%	Shares	Sole	2025-01-30
2024-09-30	$4,782	250	0.0%	Shares	Sole	2024-10-22
2024-06-30	$5,175	250	0.0%	Shares	Sole	2024-07-25
2024-03-31	$4,700	250	0.0%	Shares	Sole	2024-04-11
2023-12-31	$3,605	250	0.0%	Shares	Sole	2024-01-17
2023-09-30	$4,340	250	0.0%	Shares	Sole	2023-10-20
2023-06-30	$5,202	250	0.0%	Shares	Sole	2023-07-25
2023-03-31	$5,880	250	0.0%	Shares	Sole	2023-04-26
2022-12-31	$6,982	250	0.0%	Shares	Sole	2023-01-18
2022-09-30	$5,850	250	0.0%	Shares	Sole	2022-11-03
2022-06-30	$8,437	250	0.0%	Shares	Sole	2022-07-25
2022-03-31	$8,732	250	-4.9%	Shares	Sole	2022-05-10
2021-12-31	$8,008	263	—	Shares	Sole	2022-02-01
No filing history on record for this holder in this stock.